Liver Cancer

Early diagnosis of HCC can be cured but lack of awareness prevents some patients from receiving curative therapy. This education series will focus on treatment approaches for HCC that can potentially eliminate disparities in access to care and review care coordination strategies to optimize patient outcomes.

Because community practitioners do not specialize in one tumor type, it can be difficult to stay up to date on safety and efficacy data for targeted therapies. To help fill this gap, including nurse navigators in community cancer settings is an important addition to overcoming disparities in treatments because they improve patient outreach, coordinate care within a multidisciplinary team, and help patients and caretakers navigate the healthcare system.

Immunotherapies that can be administered in a community oncology setting are available, but unawareness of these therapies leads to the disparities in minority groups. Thus, provider education is increasingly important for equitable access to quality care for all HCC patients. Furthermore, multidisciplinary clinics have improved equity in treatment access, but barriers still exist in provider education and patient management such as variable physician attendance and need for an intensive referral infrastructure.

Multidisciplinary Hepatocellular Carcinoma Care

ACCC identified effective practices in multidisciplinary care hepatocellular carcinoma (HCC) and is providing peer-to-peer learning and resources for effective care coordination and communication.
Learn More

“HCC is a difficult disease to manage because of the multiple components of care required – no single provider can address all needs. A multidisciplinary approach puts patients at the center and results in better experience and outcomes.”
— Joel Wedd, MD, MPH, Director of the Liver Tumor Clinic, Emory Transplant Center, Emory Healthcare

Multidisciplinary HCC Care Effective Practice Guide
This report highlights effective practices in care coordination in action and provides valuable insights for cancer programs to consider. Findings from an environmental scan helped inform focus groups and interviews with three ACCC Member Programs exploring their effective practices in HCC care coordination.

Liver Cancer Heatmap
Access ACCC’s Liver Cancer Heatmap to better understand the current incidence, mortality rates, and health disparities that exist across the United States.

HCC Resource Hub
Explore this curated resource bank to learn more about screening and treatment guidelines, training opportunities, patient education, and clinical trials for HCC.

Project Partners

From Oncology Issues

From the ACCCBuzz Blog

News & Media

References

1. American Cancer Society. Cancer Facts and Figures, 2021[https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html]
2. American Cancer Society. Key Statistics about Liver Cancer [https://www.cancer.org/cancer/liver-cancer/about/what-is-key-statistics.html]
3. Bucco D. Promising Liver Cancer Treatments on the Horizon. Cure Today. [https://www.curetoday.com/view/promising-liver-cancer-treatments-on-the-horizon]
4. Dobkowski, D. Patients with HCC Positively Respond to Opdivo with Yervoy When Nexavar Was Not an Option [https://www4.curetoday.com/view/patients-with-hcc-positively-respond-to-opdivo-with-yervoy-when-nexavar-was-not-an-option]